Editorial: Drug Repurposing for COVID-19 Therapy
Front Pharmacol
.
2021 Aug 24:12:748886.
doi: 10.3389/fphar.2021.748886.
eCollection 2021.
Authors
Rafael Maldonado
1
2
,
Filippo Drago
3
4
5
Affiliations
1
Barcelona Biomedical Research Park (PRBB), University Pompeu Fabra, Barcelona, Spain.
2
IMIM (Hospital Del Mar Medical Research Institute), Barcelona, Spain.
3
Clinical Pharmacology Unit/Regional Pharmacovigilance Centre, University Hospital of Catania, Catania, Italy.
4
Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy.
5
Centre for Research and Consultancy in HTA and Drug Regulatory Affairs (CERD), University of Catania, Catania, Italy.
PMID:
34504433
PMCID:
PMC8421721
DOI:
10.3389/fphar.2021.748886
No abstract available
Keywords:
COVID-19; drug reuse; emergency; pandemic; repurposing.
Publication types
Editorial